Cargando…
Consensus in determining the resectability of locally progressed pancreatic ductal adenocarcinoma – results of the Conko-007 multicenter trial
BACKGROUND: One critical step in the therapy of patients with localized pancreatic cancer is the determination of local resectability. The decision between primary surgery versus upfront local or systemic cancer therapy seems especially to differ between pancreatic cancer centers. In our cohort stud...
Autores principales: | Wittel, U. A., Lubgan, D., Ghadimi, M., Belyaev, O., Uhl, W., Bechstein, W. O., Grützmann, R., Hohenberger, W. M., Schmid, A., Jacobasch, L., Croner, R. S., Reinacher-Schick, A., Hopt, U. T., Pirkl, A., Oettle, H., Fietkau, R., Golcher, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6805375/ https://www.ncbi.nlm.nih.gov/pubmed/31640628 http://dx.doi.org/10.1186/s12885-019-6148-5 |
Ejemplares similares
-
R0 resection following chemo (radio)therapy improves survival of primary inoperable pancreatic cancer patients. Interim results of the German randomized CONKO-007± trial
por: Fietkau, R., et al.
Publicado: (2020) -
Long-term control with chemoradiation of initially metastatic mixed adenoneuroendocrine carcinoma of the rectum: a case report
por: Semrau, S., et al.
Publicado: (2019) -
α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study
por: Sinn, M, et al.
Publicado: (2014) -
Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy)
por: Riess, Hanno, et al.
Publicado: (2008) -
Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study
por: Striefler, Jana Käthe, et al.
Publicado: (2021)